• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0001628280-23-016426
    • accounts Payable Current 13,236,000
    • accounts Receivable Net Current 48,187,000
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 41,373,000
    • accumulated Other Comprehensive Income Loss Net Of Tax 111,000
    • allocated Share Based Compensation Expense 10,259,000
    • assets 853,924,000
    • assets Current 489,271,000
    • cash And Cash Equivalents At Carrying Value 315,196,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 317,561,000
    • cik 1,581,280
    • common Stock Par Or Stated Value Per Share 1E-05
    • common Stock Shares Authorized 100,000,000
    • common Stock Shares Issued 57,105,000
    • common Stock Shares Outstanding 57,105,000
    • comprehensive Income Net Of Tax --58,436,000
    • contract With Customer Liability 1,900,000
    • contract With Customer Liability Revenue Recognized 1,400,000
    • date Filed 2023-05-08
    • document Fiscal Period Focus Q2
    • document Fiscal Year Focus 2,023
    • document Type 10-Q
    • earnings Per Share Basic -1.04
    • earnings Per Share Diluted -1.04
    • entity Name Twist Bioscience Corp
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --58,480,000
    • income Tax Expense Benefit 676,000
    • interest Expense 2,000
    • inventory Net 39,923,000
    • irs Number 462,058,888
    • lessee Operating Lease Liability Payments Due 146,582,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 14,194,000
    • lessee Operating Lease Liability Payments Due Year Four 7,265,000
    • lessee Operating Lease Liability Payments Due Year Three 12,609,000
    • lessee Operating Lease Liability Payments Due Year Two 14,066,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 55,362,000
    • liabilities 149,992,000
    • liabilities And Stockholders Equity 853,924,000
    • liabilities Current 72,108,000
    • net Income Loss --59,156,000
    • operating Income Loss --61,637,000
    • operating Lease Liability 91,220,000
    • operating Lease Liability Current 13,396,000
    • operating Lease Liability Noncurrent 77,824,000
    • operating Lease Payments 4,000,000
    • operating Lease Right Of Use Asset 70,669,000
    • other Assets Noncurrent 2,201,000
    • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 73,000
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 647,000
    • other Liabilities Current 10,040,000
    • other Liabilities Noncurrent 60,000
    • other Nonoperating Income Expense --305,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 187,912,000
    • property Plant And Equipment Net 146,539,000
    • report Link https://www.sec.gov/Archives/edgar/data/1581280/000162828023016426/twst-20230331_htm.xml
    • research And Development Expense 27,379,000
    • retained Earnings Accumulated Deficit --929,400,000
    • selling General And Administrative Expense 53,965,000
    • stockholders Equity 703,932,000
    • trading Symbol TWST
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 56,777,000
    • weighted Average Number Of Shares Outstanding Basic 56,777,000
    • id REPORTED_FINANCIALS
    • key TWST
    • subkey 10-Q
    • date 2023-05-08
    • updated 2023-05-09
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

TWST stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001628280-23-016426
  • accounts Payable Current 13,236,000
  • accounts Receivable Net Current 48,187,000
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 41,373,000
  • accumulated Other Comprehensive Income Loss Net Of Tax 111,000
  • allocated Share Based Compensation Expense 10,259,000
  • assets 853,924,000
  • assets Current 489,271,000
  • cash And Cash Equivalents At Carrying Value 315,196,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 317,561,000
  • cik 1,581,280
  • common Stock Par Or Stated Value Per Share 1E-05
  • common Stock Shares Authorized 100,000,000
  • common Stock Shares Issued 57,105,000
  • common Stock Shares Outstanding 57,105,000
  • comprehensive Income Net Of Tax --58,436,000
  • contract With Customer Liability 1,900,000
  • contract With Customer Liability Revenue Recognized 1,400,000
  • date Filed 2023-05-08
  • document Fiscal Period Focus Q2
  • document Fiscal Year Focus 2,023
  • document Type 10-Q
  • earnings Per Share Basic -1.04
  • earnings Per Share Diluted -1.04
  • entity Name Twist Bioscience Corp
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --58,480,000
  • income Tax Expense Benefit 676,000
  • interest Expense 2,000
  • inventory Net 39,923,000
  • irs Number 462,058,888
  • lessee Operating Lease Liability Payments Due 146,582,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 14,194,000
  • lessee Operating Lease Liability Payments Due Year Four 7,265,000
  • lessee Operating Lease Liability Payments Due Year Three 12,609,000
  • lessee Operating Lease Liability Payments Due Year Two 14,066,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 55,362,000
  • liabilities 149,992,000
  • liabilities And Stockholders Equity 853,924,000
  • liabilities Current 72,108,000
  • net Income Loss --59,156,000
  • operating Income Loss --61,637,000
  • operating Lease Liability 91,220,000
  • operating Lease Liability Current 13,396,000
  • operating Lease Liability Noncurrent 77,824,000
  • operating Lease Payments 4,000,000
  • operating Lease Right Of Use Asset 70,669,000
  • other Assets Noncurrent 2,201,000
  • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 73,000
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 647,000
  • other Liabilities Current 10,040,000
  • other Liabilities Noncurrent 60,000
  • other Nonoperating Income Expense --305,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 187,912,000
  • property Plant And Equipment Net 146,539,000
  • report Link https://www.sec.gov/Archives/edgar/data/1581280/000162828023016426/twst-20230331_htm.xml
  • research And Development Expense 27,379,000
  • retained Earnings Accumulated Deficit --929,400,000
  • selling General And Administrative Expense 53,965,000
  • stockholders Equity 703,932,000
  • trading Symbol TWST
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 56,777,000
  • weighted Average Number Of Shares Outstanding Basic 56,777,000
  • id REPORTED_FINANCIALS
  • key TWST
  • subkey 10-Q
  • date 2023-05-08
  • updated 2023-05-09